This antibody was purified from mouse ascites fluid using protein A agarose beads. This hybridoma was established by fusion of mouse myeloma cell P3U1 with Balb/c splenocyte immunized with CHO cell expressing full length human Podocalyxin/PCLP1.
Target:
PCLP1
Application Dilute:
FCM: 10-20 µg/mL (final concentration)
* VAT and and shipping costs not included. Errors and price changes excepted